BioPharma Restorative treatments for osteoarthritis There’s no cure for osteoarthritis. Current treatment for this debilitating joint disease involves managing symptoms and replacing joints. Professor Francesco Dell’Accio and his team have invented three novel and...
BioPharma Using n-3 DPA-derived Resolvins to assess the risk of Cardiovascular Diseases A novel therapeutic strategy, using n-3 DPA-derived resolvins to treat or prevent cardiovascular disease. Circadian rhythms play a key role in regulating various physiological...
BioPharma Restoring Erythropoiesis in Myelodysplastic Syndrome Researchers at QMUL and Université de Bretagne-Occidentale have developed a method of restoring erythropoiesis in a patient suffering from a SF3B1 mutant myelodysplastic syndrome, involving the...
BioPharma Repurposing an anti-cancer agent to treat heart failure A novel method for the prevention and treatment of heart failure, using αvβ3- and αvβ5-integrin targeting agents. The method has been shown to promote normal cardiac angiogenesis, endothelial cell...
BioPharma Developing inhibitors to target activated fibroblasts A drug discovery program has led to promising and selective pharmacological inhibitors to target activated fibroblasts in cancer and other fibrotic diseases. Researchers have identified a target that when...